Skip to main content
. Author manuscript; available in PMC: 2018 Jul 3.
Published in final edited form as: Curr Opin Gastroenterol. 2016 Sep;32(5):394–400. doi: 10.1097/MOG.0000000000000295

Table 1.

Transcriptome-based molecular subtypes of human pancreatic cancer and stroma and their effects on survival

Classification Molecular subtype Effect on survival
Collisson et al. [3] Quasimesenchymal 1
Exocrine-like
Classical
Bailey et al. [4▪▪] Squamous 1
ADEX2
Pancreatic progenitor 3
Immunogenic 4
Moffitt et al. [5] Basal-like5 1
Classical6
‘Normal’ stroma
‘Activated’ stroma 7
1

This group has the worst survival in the respective classification.

2

Aberrantly differentiated endocrine and exocrine.

3

Within the progenitor group, patients with a higher expression of genes in this gene program have a worse prognosis.

4

Within the immunogenic group, high macrophage and T-cell coinhibition signatures are associated with a worse prognosis.

5

The basal group only partially overlaps with the quasimesenchymal group.

6

The classical group only partially overlaps with the Collisson classical group.

7

‘Activated’ stroma was associated with a worse prognosis when compared with ‘normal’ stroma. Stromal types are not tumor subtype specific.

The different classification schemes by the authors are shown. The matching colors correspond to overlapping groups under the different classification schemes. The Moffitt tumor subtypes only have partial overlap with the other corresponding groups.